Literature DB >> 19294566

Intraocular lymphoma: more questions than answers.

Denis Wakefield1, Manfred Zierhut.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19294566     DOI： 10.1080/09273940902834413

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN： 0927-3948            Impact factor:   3.070


× No keyword cloud information.
  6 in total

1.  Clinical features and diagnostic significance of the intraocular fluid of 217 patients with intraocular lymphoma.

Authors:  Keisuke Kimura; Yoshihiko Usui; Hiroshi Goto
Journal:  Jpn J Ophthalmol       Date:  2012-06-05       Impact factor: 2.447

2.  Risk factors for failure of vitrectomy cell block technique in cytological diagnosis of vitreoretinal lymphoma.

Authors:  Takako Ito; Atsunobu Takeda; Kohta Fujiwara; Eiichi Hasegawa; Shintaro Nakao; Yoshihiro Ohishi; Yoshinao Oda; Hiroshi Yoshikawa; Koh-Hei Sonoda
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-03-13       Impact factor: 3.117

3.  25-gauge transconjunctival diagnostic vitrectomy in suspected cases of intraocular lymphoma: a case series and review of the literature.

Authors:  Mozhgan Rezaei Kanavi; Masoud Soheilian; Sayed Bagher Hosseini; Amir A Azari
Journal:  Int J Ophthalmol       Date:  2014-06-18       Impact factor: 1.779

4.  The future of primary intraocular lymphoma (retinal lymphoma).

Authors:  Chi-Chao Chan; Sylvain Fisson; Bahram Bodaghi
Journal:  Ocul Immunol Inflamm       Date:  2009 Nov-Dec       Impact factor: 3.070

Review 5.  Primary intraocular lymphoma: diagnosis and differential diagnosis.

Authors:  H Nida Sen; Bahram Bodaghi; Phuc Le Hoang; Robert Nussenblatt
Journal:  Ocul Immunol Inflamm       Date:  2009 May-Jun       Impact factor: 3.070

Review 6.  Evidence-based expert consensus on the management of primary central nervous system lymphoma in China.

Authors:  Tong Chen; Yuanbo Liu; Yang Wang; Qing Chang; Jinsong Wu; Zhiliang Wang; Daoying Geng; Jin-Tai Yu; Yuan Li; Xiao-Qiu Li; Hong Chen; Dongxiao Zhuang; Jianyong Li; Bin Wang; Tao Jiang; Lanting Lyu; Yuqin Song; Xiaoguang Qiu; Wenbin Li; Song Lin; Xinghu Zhang; Dehong Lu; Junqiang Lei; Yaolong Chen; Ying Mao
Journal:  J Hematol Oncol       Date:  2022-09-29       Impact factor: 23.168
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.